News Results

  1. Trading Day: The AI train rolls on
    Reuters | 05:05 PM EDT

    World stocks, the S&P 500 and Nasdaq rose to new highs on Tuesday, driven again by an unyielding optimism around artificial intelligence that lifted U.S. chipmaker Micron Technology into the $1 trillion club and offset uncertainty around a U.S.-Iran peace deal. In my column today, I look at how the steep selloff in U.S. Treasuries has made some corporate bonds more appealing than sovereign debt.

  2. TRADING DAY-The AI train rolls on
    Reuters | 05:00 PM EDT

    World stocks, the S&P 500 and Nasdaq rose to new highs on Tuesday, driven again by an unyielding optimism around artificial intelligence that lifted U.S. chipmaker Micron Technology into the $1 trillion club and offset uncertainty around a U.S.-Iran peace deal. In my column today, I look at how the steep selloff in U.S. Treasuries has made some corporate bonds more appealing than sovereign debt.

  3. US plans tariffs on USMCA countries, has issues with Canada
    Reuters | 05:00 PM EDT

    The Trump administration's top trade official said on Tuesday that the U.S. plans tariffs on its North American free trade partners and has significant trade issues with Canada. "We're going to have tariffs as long as we have a giant trade deficit," U.S. Trade Representative Jamieson Greer said at a forum.

  4. GLOBAL MARKETS-S&P 500, Nasdaq nab record closing highs, WTI crude falls on hopes for Iran peace deal
    Reuters | 04:33 PM EDT

    * Chip prices surge, putting Nasdaq out front. * Brent crude rises, WTI falls as US strikes on Iran dampen peace hopes. * ECB's Isabel Schnabel signals need for rate hike in June regardless of peace progress. * US Treasury yields fall as inflation worries ebb. By Stephen Culp.

  5. Viridian Therapeutics signs manufacturing deal with WuXi Biologics for thyroid eye disease drug
    Reuters | 04:29 PM EDT

    Viridian Therapeutics (VRDN) said on Tuesday it has signed a manufacturing agreement with WuXi Biologics (WXIBF) to support commercial supply of its experimental drug if approved. * WuXi Biologics (WXIBF) will make and supply both the drug substance and final product for veligrotug, Viridian's treatment for thyroid eye disease, a condition that causes eye swelling and vision problems.

  6. TREASURIES-US yields fall on hopes potential Strait of Hormuz deal can cool inflation
    Reuters | 04:18 PM EDT

    Yields on U.S. government bonds held to lower levelson Tuesday, as hopes for a breakthrough deal to reopen the Strait of Hormuz had investors relaxing a bit about the inflation outlook at the start of a holiday-shortened week featuring major U.S. economic data releases.

  7. FOREX-Dollar climbs as US strikes on Iran dent ceasefire optimism
    Reuters | 03:56 PM EDT

    * Dollar rises against euro and Swiss franc. * Iran says U.S. has violated ceasefire after fresh U.S. attacks. * Prospect of Strait of Hormuz reopening had lifted risk appetite. * Safe-haven dollar finds favour as investors turn more cautious. By Chibuike Oguh.

  8. Brent crude jumps 4%, as US strikes in Iran set back hopes for Hormuz re-opening
    Reuters | 03:28 PM EDT

    * U.S. strikes in Iran spark renewed Middle East. * Strait of Hormuz shipping remains restricted, some tankers pass amid ongoing risks. * U.S. consumer confidence dips as inflation fears rise due to Iran conflict. * U.S. futures fall, catching up to Brent's Monday selloff. By Scott DiSavino.

  9. BRIEF-Moody's Ratings Assigns Aa1 To State Of Maine's GO Bonds; Outlook Stable
    Reuters | 01:49 PM EDT

    Moody's: * MOODY'S RATINGS ASSIGNS AA1 TO STATE OF MAINE'S GO BONDS; OUTLOOK STABLE Source text:

  10. Inflation worries weigh on US consumer confidence in May
    Reuters | 01:34 PM EDT

    * Consumer confidence index decreases 0.7 points to 93.1 in May. * Share of consumers viewing jobs as not plentiful at highest level since 2021. * Consumers' write-in responses on factors affecting the economy continued to skew towards pessimism. By Lucia Mutikani.

In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation risk and credit and default risks for both issuers and counterparties. Unlike individual bonds, most bond funds do not have a maturity date, so avoiding losses caused by price volatility by holding them until maturity is not possible.

Lower-quality debt securities generally offer higher yields, but also involve greater risk of default or price changes due to potential changes in the credit quality of the issuer. Any fixed income security sold or redeemed prior to maturity may be subject to loss.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.

fir_news_results